Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions. - Wikidata - wikimedia - TriplyDB

Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions.

Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions.

http://www.wikidata.org/entity/Q35148175

about

Key roles for MYC, KIT and RET signaling in secondary angiosarcomas Radiation-associated neoplasia: clinical, pathological and genomic correlates.Case report: whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapies Recurrent PTPRB and PLCG1 mutations in angiosarcoma.Genomic profiling reveals extensive heterogeneity in somatic DNA copy number aberrations of canine hemangiosarcoma Post-radiation atypical vascular lesion/angiosarcoma arising in the larynx FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations.The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification New therapeutic targets in soft tissue sarcoma.A transcriptome signature of endothelial lymphatic cells coexists with the chronic oxidative stress signature in radiation-induced post-radiotherapy breast angiosarcomas.Aberrations in Angiogenic Signaling and MYC Amplifications are Distinguishing Features of Angiosarcoma.Malignant vascular tumors--an update.Sarcoma classification: an update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone.MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study.c-MYC is a radiosensitive locus in human breast cells Why do patients with radiation-induced sarcomas have a poor sarcoma-related survival?Enrichment of the embryonic stem cell reprogramming factors Oct4, Nanog, Myc, and Sox2 in benign and malignant vascular tumors.Frequent FOS Gene Rearrangements in Epithelioid Hemangioma: A Molecular Study of 58 Cases With Morphologic Reappraisal.Primary and secondary angiosarcomas: a comparative single-center analysis.Well-differentiated angiosarcoma of spleen: a teaching case mimicking hemagioma and cytogenetic analysis with array comparative genomic hybridization.Alterations of the p53 and PIK3CA/AKT/mTOR pathways in angiosarcomas: a pattern distinct from other sarcomas with complex genomics.Radiation-associated angiosarcoma in the setting of breast cancer mimicking radiation dermatitis: A diagnostic pitfall.Targeted massively parallel sequencing of angiosarcomas reveals frequent activation of the mitogen activated protein kinase pathway Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma.Diagnostic Immunohistochemistry in Cutaneous Neoplasia: An Update Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.Does radiation-induced c-MYC amplification initiate breast oncogenesis?Pharmacologic inhibition of MEK signaling prevents growth of canine hemangiosarcoma Radiotherapy-Associated Long-term Modification of Expression of the Inflammatory Biomarker Genes ARG1, BCL2L1, and MYC.Advances in the systemic treatment of cutaneous sarcomas.Postradiation sarcoma: morphological findings on fine-needle aspiration with clinical correlation.The evolving classification of soft tissue tumours - an update based on the new 2013 WHO classification.Molecular diagnosis of soft tissue neoplasia: clinical applications and recent advances.c-myc in Kaposi's sarcoma: analyses by fluorescent in situ hybridization and immunohistochemistry.Role of genetic and molecular profiling in sarcomas.Sarcoma of the breast: an update on a rare entity.Advances in the clinicopathological and molecular classification of cutaneous mesenchymal neoplasms.Modern therapies and iatrogenic changes in breast pathology.Value of combined cytology and molecular information in the diagnosis of soft tissue tumors.Kutane Sarkome.

P2860

Q28390442-3F8DA11C-0CEE-447F-A8D2-FE00EE2FC303 Q30240080-4AFE7222-E7F9-49CD-82F7-97FC66D8ADCD Q30834078-85547CA8-B785-4F84-A186-2DF0AB882615 Q33657848-5F7C29E7-7DBF-4B91-A740-6BF0E4AAC982 Q33919862-732B8EDA-9F38-4A56-AF44-2EA5BF6C64C2 Q34021217-E40D7AE5-08C6-49B6-A948-7476A780803C Q34084740-17449E8A-B124-4721-BED5-14782557B808 Q34181123-918A4A18-5FD8-43F6-83D6-C246EA356178 Q34267924-FA81BC5F-7398-4ED0-A7F9-A548E3A06CF4 Q34270766-EBD93AD4-990C-4971-A936-5694349FA97B Q34443645-6C48CF44-7457-4038-987F-19EC6BE0969F Q34658662-DDE1111A-0C41-477E-A25F-E5FBE387AB38 Q34660467-65E16518-0F3D-4D62-BB3E-F6D6AB8524C9 Q35007637-A5B7E88F-AA99-42FC-8A3E-8E431C740588 Q35348121-05767F0A-E53B-4121-9CD7-A8BF44951061 Q35682001-AA05B366-C710-4DC9-A8F6-BB78536C338B Q35790043-CA6E570E-E562-4F23-976A-E0EBD76A98BC Q36054323-E64DEC19-8468-431F-A8A5-EABC7BE2C092 Q36091977-AC47223B-555E-44DF-8CC8-CA07A940D640 Q36155613-4A88D50D-209A-4D64-96D9-B6D703C45C50 Q36210054-0EA644BC-6F6F-4ED6-8FF2-C40228CAD48B Q36272659-E94A8B28-0B4F-4211-B726-144185A68856 Q36546559-8AB965BB-AC61-460D-9390-53B9F593A179 Q36546673-9BF51618-4F96-4FC5-9F7D-0C965693E66E Q36752423-B4813148-F05C-454B-A293-AAFC3093F32A Q36803294-2556E843-B3EB-4549-92ED-08215B803FD2 Q36836096-C29BBE37-62A9-4DD7-9F83-FAFE3768AA01 Q37161161-9E502FD0-956D-4F68-82CA-53541FB1AD35 Q37743903-CEC0FEEC-686D-4F66-97B1-7A9CCC217584 Q38000872-9D5DC670-1D1C-4FB7-A4A3-22AE17B35083 Q38003960-41911E53-DEE6-44C7-B731-DE95499E04B1 Q38155908-DF4FA408-6376-48D6-B5C1-45A2B4B86107 Q38238574-41CC111C-F456-4263-A9F0-8373AFF8E8D8 Q38401727-2691A5A7-9BB8-4033-BF60-5E056ADD12DD Q38458016-68EC0288-107E-4E91-A8DC-A5C83CC82B65 Q38686290-130BB9C7-6E0D-40D3-99BA-6A78259E2117 Q38695749-F0BEB014-6B2B-42BE-89B8-C4299E8A2F80 Q39037636-33788855-C3A8-48F0-BA7E-4D26EA830971 Q39079708-A0EF4018-E90F-45C3-8FEE-501B4AF606B4 Q39357839-C04AD06F-E781-433B-B620-5DE162E5CB9D

P2860

Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions.

http://www.wikidata.org/entity/Q35148175

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Consistent MYC and FLT4 gene a ...... ted atypical vascular lesions.

@ast

Consistent MYC and FLT4 gene a ...... ted atypical vascular lesions.

@en

type

label

Consistent MYC and FLT4 gene a ...... ted atypical vascular lesions.

@ast

Consistent MYC and FLT4 gene a ...... ted atypical vascular lesions.

@en

prefLabel

Consistent MYC and FLT4 gene a ...... ted atypical vascular lesions.

@ast

Consistent MYC and FLT4 gene a ...... ted atypical vascular lesions.

@en

P1433

Q35148175-E3B345B4-6E72-4905-89FA-E9A53EE0A71F

P1476

Q35148175-34C28273-A83C-44A2-9226-54EF20295048

P2093

Q35148175-090BD349-E415-4A6D-AC7B-262E4668AEC7

Q35148175-25450BFC-2895-4C57-B8ED-DE3A2B5ECC24

Q35148175-38AB2921-BDC8-4B94-9A5B-9BC44125AE10

Q35148175-9BDF6954-0549-431D-931B-A328FC34E01A

Q35148175-A02EAB9D-15FE-4296-84E3-9CA4FF97A7AD

Q35148175-D1AFFC13-40A6-4F24-8988-2F6663F32F33

P2860

Q35148175-0564C33F-11C4-4B08-99DC-9BBB2D66D9D4

Q35148175-0DEA8584-427A-4AE9-BA1B-E6753F5CF1E5

Q35148175-1F2478EE-D6BC-44FE-9306-2026EA5AFE4E

Q35148175-2D7A6298-2C1A-4F20-B945-5C8E8486C88C

Q35148175-408D815D-349A-4D42-9B4C-23BA547EA198

Q35148175-43FD325E-2819-4619-A96B-33D73EAA9014

Q35148175-66A781C7-DD1A-4F64-9AFE-3D2AE3047BA9

Q35148175-6D10F648-16AE-4EDC-BDAC-CF8EDD0E89D0

Q35148175-7EFEE4C0-4D4B-4ADB-B02D-033435E7CFDE

Q35148175-7FA6D942-A60E-4DB1-93CD-D3DC581D2612

P304

Q35148175-2281B8DE-3FE5-4E9F-A1B1-324F7CDD204A

P31

Q35148175-B41AB937-5AB0-4801-9842-06147B009B74

P356

Q35148175-E90DB07B-D768-4588-8EA1-A48370D9F6F1

P433

Q35148175-CB9ACCC9-DF2D-4D94-A6AA-17215371292D

P478

Q35148175-35383C53-B9C0-4024-BA0F-351419AA9147

P577

Q35148175-448FBFC6-4108-4FC3-9232-3C967E4FCCED

P5875

Q35148175-36FA934F-3B9D-4E7D-9805-C149881BF3B0

P698

Q35148175-AC42B98A-9BDA-4656-BF81-1E4CC114394F

P932

Q35148175-D89757AD-9E81-496F-9779-50D8FB3B36D9

P356

P1433

Genes, Chromosomes and Cancer

P1476

Consistent MYC and FLT4 gene a ...... ted atypical vascular lesions.

@en

P2093

Cristina R Antonescu

http://www.w3.org/2001/XMLSchema#string

Lei Zhang

http://www.w3.org/2001/XMLSchema#string

Ning-En Chang

http://www.w3.org/2001/XMLSchema#string

Robert G Maki

http://www.w3.org/2001/XMLSchema#string

Samuel Singer

http://www.w3.org/2001/XMLSchema#string

Tianhua Guo

http://www.w3.org/2001/XMLSchema#string

P2860

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema

KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors

Utilization management and data acquisition: a case study.

MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema

Translocation joins c-myc and immunoglobulin gamma 1 genes in a Burkitt lymphoma revealing a third exon in the c-myc oncogene.

Post-radiation sarcomas: a review of the clinical and imaging features in 63 cases.

Overexpression of c-Myc alters G(1)/S arrest following ionizing radiation

Endothelial cell diversity revealed by global expression profiling.

Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells.

Identification of downstream-initiated c-Myc proteins which are dominant-negative inhibitors of transactivation by full-length c-Myc proteins.

P304

25-33

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/GCC.20827

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47431007

http://www.w3.org/2001/XMLSchema#string

P698

20949568

http://www.w3.org/2001/XMLSchema#string

P932

3150534

http://www.w3.org/2001/XMLSchema#string